Ebola Vaccine Case Studies

The vaccine we have designed will be delivered through a shot intramuscularly. In this respect it will be delivered in the same area that a normal flu virus vaccine would. This vaccine will be delivered once before the patient has gotten the Ebola virus, because Ebola is not constantly changing like the flu virus and will not need a new vaccine every year unless the disease mutates. Since we predict the virus won’t be constantly changing, a one-time delivery to the patients would be the best option. As for our timing, administering this drug before Ebola is caught is important, as well as the best time to administer the vaccine, because it is a prophylactic vaccine, designed to be taken before a disease is contracted. Furthermore, we will …show more content…
Monkeys are the perfect choice for this study, given that they have the closest immune systems to those of the human model. As such the monkeys will be given the Ebola vaccine and then a titer test will be performed and the results checked to see if the vaccine is actually working as planned or must be altered. The titer should show the presence of antibodies if the vaccine is working and be high in antibodies if there is a presence of Ebola in the sample. If the sample shows no antibodies then that means that the vaccine is not …show more content…
The reason that this vaccine is a better fit for prospective patients is because a live virus would have to be refrigerated and kept cool. That poses a problem for the recipients, namely those in rural African villages who will be receiving the vaccine but not have common access to a refrigerator or other means to keep the vaccine at its appropriate and necessary temperature. We hope that by producing a vaccine such as the one outlined above, it will become easier to prevent the deadly spread of Ebola in disadvantaged parts of the world, and as such it is a key concern that the vaccine be not only as efficient, but as hardy as possible in order to survive the transportation and storage required to distribute it. Another reason is our vaccine will be given through injection whereas others are done through a nasal spray. The nasal spray is a live attenuated vaccine, which means that there is a chance that the patient could get the Ebola virus instead of being immune to it (AAPS,